生物種
|
リソース名
|
RRC ID
|
タイトル
|
ジャーナル
|
公開日
|
外部リンク
|
ヒト・動物細胞
|
JMSU1(RCB2227)
|
78092
|
Discovery of lirafugratinib (RLY-4008), a highly selective irreversible small-molecule inhibitor of FGFR2.
|
Proc Natl Acad Sci U S A |
2024-2-6 |
Pubmed
Full text
|
ヒト・動物細胞
|
KP4(RCB1005)
|
77543
|
LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models.
|
Invest New Drugs |
2013-8-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
PC-9(RCB4455)
|
68844
|
Design, synthesis and evaluation of the osimertinib analogue (C-005) as potent EGFR inhibitor against NSCLC.
|
Bioorg Med Chem |
2018-12-15 |
Pubmed
Full text
|
ヒト・動物細胞
|
Ba/F3(RCB4476)
|
68837
|
Lamellarin 14, a derivative of marine alkaloids, inhibits the T790M/C797S mutant epidermal growth factor receptor.
|
Cancer Sci |
2021-5-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
RERF-LC-AI(RCB0444)
|
67754
|
A unique hinge binder of extremely selective aminopyridine-based Mps1 (TTK) kinase inhibitors with cellular activity.
|
Bioorg Med Chem |
2015-5-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
HuH-7
|
67469
|
First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway.
|
Cancer Discov |
2015-4-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
Lu99(RCB1900)
|
67417
|
Discovery of imidazo[1,2-b]pyridazine derivatives: selective and orally available Mps1 (TTK) kinase inhibitors exhibiting remarkable antiproliferative activity.
|
J Med Chem |
2015-2-26 |
Pubmed
Full text
|
ヒト・動物細胞
|
Ba/F3(RCB0805)
,
WEHI-3(RCB0035)
|
67408
|
EGFR Exon 18 Mutations in Lung Cancer: Molecular Predictors of Augmented Sensitivity to Afatinib or Neratinib as Compared with First- or Third-Generation TKIs.
|
Clin Cancer Res |
2015-12-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
HuCCT1(RCB1960)
,
RBE(RCB1292)
,
SSP-25(RCB1293)
,
HuH-28(RCB1943)
|
66894
|
TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion-Positive Intrahepatic Cholangiocarcinoma.
|
Cancer Discov |
2019-8-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
Ba/F3
|
65869
|
Characterization of EGFR T790M, L792F, and C797S Mutations as Mechanisms of Acquired Resistance to Afatinib in Lung Cancer.
|
Mol Cancer Ther |
2017-2-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
293T(RCB2202)
|
65722
|
Anti-tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC-dependent vulnerability.
|
EMBO Mol Med |
2018-6-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
Li-7(RCB1941)
|
65145
|
ASP5878, a Novel Inhibitor of FGFR1, 2, 3, and 4, Inhibits the Growth of FGF19-Expressing Hepatocellular Carcinoma.
|
Mol Cancer Ther |
2017-1-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
PC-9(RCB4455)
|
65019
|
Discovery of 1-{(3R,4R)-3-[({5-Chloro-2-[(1-methyl-1H-pyrazol-4-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}oxy)methyl]-4-methoxypyrrolidin-1-yl}prop-2-en-1-one (PF-06459988), a Potent, WT Sparing, Irreversible Inhibitor of T790M-Containing EGFR Mutants.
|
J Med Chem |
2016-3-10 |
Pubmed
Full text
|
ヒト・動物細胞
|
Ba/F3(RCB0805)
,
LC-2/ad(RCB0440)
|
64211
|
Alectinib shows potent antitumor activity against RET-rearranged non-small cell lung cancer.
|
Mol Cancer Ther |
2014-12-1 |
Pubmed
Full text
|
シロイヌナズナ / 植物培養細胞・遺伝子
|
rpc00008
|
63920
|
Identification of novel compounds that inhibit SnRK2 kinase activity by high-throughput screening.
|
Biochem Biophys Res Commun |
2020-12-29 |
Pubmed
Full text
|
ヒト・動物細胞
|
PC-3(RCB2145)
|
63137
|
PNU-120596, a positive allosteric modulator of α7 nicotinic acetylcholine receptor, directly inhibits p38 MAPK.
|
Biochem Pharmacol |
2020-12-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
MKN45(RCB1001)
|
61696
|
In Vitro and In Vivo Activity of AMG 337, a Potent and Selective MET Kinase Inhibitor, in MET-Dependent Cancer Models.
|
Mol Cancer Ther |
2016-7-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
MCF7(RCB1904)
,
A549(RCB0098)
|
61366
|
Design, synthesis and biological evaluation of a new series of thiazolyl-pyrazolines as dual EGFR and HER2 inhibitors.
|
Eur J Med Chem |
2019-11-15 |
Pubmed
Full text
|
ヒト・動物細胞
|
A549(RCB0098)
,
MCF7(RCB1904)
|
59803
|
Design, Synthesis and Biological Evaluation of Pentacyclic Triterpene Derivatives: Optimization of Anti-ABL Kinase Activity.
|
Molecules |
2019-1-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
OCUB-M(RCB0881)
|
58881
|
Development of a potent and orally active activator of adenosine monophosphate-activated protein kinase (AMPK), ASP4132, as a clinical candidate for the treatment of human cancer.
|
Bioorg Med Chem |
2020-3-1 |
Pubmed
Full text
|